NCT02923271 is a NA clinical trial of CellControl in Teen Drivers, sponsored by Children's Hospital of Philadelphia.

Who is sponsoring NCT02923271?

NCT02923271 is sponsored by Children's Hospital of Philadelphia.

What drugs are being tested in NCT02923271?

Interventions in NCT02923271: CellControl.

What condition does NCT02923271 study?

NCT02923271 studies Teen Drivers, Motor Vehicle Accidents.

Is NCT02923271 still recruiting?

NCT02923271 is currently completed. Last updated 20 August 2019.

Are results published for NCT02923271?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-08-20 · How we verify

NCT02923271

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Intrafamily Accountability for Reducing Cellphone Use While Driving in Adults and Their Teen Children

Completed NA Results posted Last updated 20 August 2019

What this trial tests

NA trial testing CellControl in Teen Drivers in 34 participants. Completed in 16 November 2017.

Timeline

7 December 2016

Primary endpoint
13 September 2017

16 November 2017

Quick facts

Lead sponsor	Children's Hospital of Philadelphia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	34
Start date	7 December 2016
Primary completion	13 September 2017
Estimated completion	16 November 2017
Sites	2 locations across United States

Drugs / interventions tested

CellControl

Conditions studied

Teen Drivers — all drugs for Teen Drivers →
Motor Vehicle Accidents — all drugs for Motor Vehicle Accidents →

Sponsor

Children's Hospital of Philadelphia

Who can join

Adults 16 to 17, any sex, with Teen Drivers or Motor Vehicle Accidents. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Number of Cellphone Unlocks Per Hour of Drive Time Primary · 8 weeks

Change in number of cellphone unlocks per hour of drive time between baseline and the end of the intervention period

Group	Value	95% CI
Teen-Parent Monitoring Group	0.81	± 1.25
Teen Only Monitoring Group	3.61	± 9.32

Change in the Number of Minutes of Phone Use Per Hour of Driving Secondary · 8 weeks

Change in the number of minutes of phone use per hour of driving between baseline and the end of the intervention

Group	Value	95% CI
Teen-Parent Monitoring Group	-4.23	± 5.75
Teen Only Monitoring Group	-6.32	± 6.71

Sponsor's own description

Research participants and their parents will be recruited to take part in a randomized control trial. Participants' and their parents' cellphone use will be observed during an initial baseline period. Participants and their parents will then be randomly assigned to one of two conditions: opt-out blocking with parental notification, opt-out blocking with bidirectional notification.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital of Philadelphia trials

Trials by the same sponsor.

NCT07023380 — EoE Food Test Pilot Study · NA · not yet recruiting
NCT06693752 — CEUS Evaluation of Hydrocephalus in Neonates and Infants · Phase 2 · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07444528 — Upper Airway Ultrasound to Predict Difficult Laryngoscopy in Neonates and Infants · enrolling by invitation
NCT07321327 — Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2 · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02923271 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Philadelphia
Last refreshed: 20 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02923271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing